| 1 |
24770794 | Fewer fluctuations, higher maximum concentration and better motor response of levodopa with catechol-O-methyltransferase inhibition. | 2014 Nov |
1 |
| 2 |
22136163 | Levodopa infusion combined with entacapone or tolcapone in Parkinson disease: a pilot trial. | 2012 Jun |
1 |
| 3 |
20077469 | The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF. | 2010 Feb 15 |
1 |
| 4 |
19922897 | Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects. | 2009 Oct |
1 |
| 5 |
17948613 | Understanding Parkinson's disease: an update on current diagnostic and treatment strategies. | 2006 Sep |
2 |
| 6 |
15090932 | Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/carbidopa. | 2004 Jan-Feb |
2 |
| 7 |
10882160 | Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease. | 2000 Jun |
2 |
| 8 |
10981253 | Entacapone. | 2000 Sep |
1 |
| 9 |
11147508 | Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients. | 2000 |
2 |
| 10 |
10510160 | COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet). | 1999 Sep |
1 |
| 11 |
9403227 | Effect of tolcapone on plasma levodopa concentrations after coadministration with levodopa/carbidopa to healthy volunteers. | 1997 Dec |
1 |
| 12 |
8665546 | Acute effects of COMT inhibition on L-DOPA pharmacokinetics in patients treated with carbidopa and selegiline. | 1995 Aug |
1 |
| 13 |
8787797 | Pharmacokinetic model of oral levodopa and role of carbidopa in parkinsonian patients. | 1995 Dec |
1 |
| 14 |
8255478 | Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients. | 1993 Dec |
1 |
| 15 |
3111485 | Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521. | 1987 Aug 1 |
1 |
| 16 |
7447951 | Benserazide and carbidopa as substrates of catechol-O-methyltransferase: new mechanism of action in Parkinson's disease. | 1980 Dec 1 |
1 |